Olympus Finalizes Orthopedic Business Divestiture
Company Announcements

Olympus Finalizes Orthopedic Business Divestiture

Olympus (JP:7733) has released an update.

Olympus Corporation has successfully completed the transfer of its Orthopedic Business to entities established by Polaris Capital Group Co., Ltd. on July 12, 2024. The deal, which includes the sale of all shares of its subsidiaries Olympus Terumo Biomaterials Corporation and FH Ortho SAS, is expected to have an immaterial impact on Olympus’s consolidated operating profit for the fiscal year ending March 31, 2025.

For further insights into JP:7733 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Japan Auto-Generated NewsdeskOlympus CEO Resigns Amid Allegations
TipRanks Japan Auto-Generated NewsdeskOlympus Resolves Legal Dispute in China
TipRanks Japan Auto-Generated NewsdeskOlympus Advances Share Repurchase Program
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App